Jeanne Thoma Biography and Net Worth

Ms. Thoma was appointed to the Board of Directors in December 2020. Ms. Thoma is a seasoned pharmaceutical industry executive with more than 30 years of experience spanning product development and commercialization, as well as operations and supply chain management. She most recently served as president and chief executive officer of SPI Pharma Inc., a global pharmaceuticals ingredients company and an innovative solutions provider of ingredients and drug delivery systems. Prior to SPI, Ms. Thoma held positions of increasing responsibility at Lonza AG, a Switzerland-based biotech company, most recently as president and chief operating officer of the microbial control business sector. Before joining Lonza, she spent 14 years within the pharma solutions business at BASF Corporation, during which time she held various leadership positions in the areas of sales, marketing and operations. Ms. Thoma is a member of the board of advisors for the Drug Chemical and Associated Technologies Association (DCAT) and currently sits on the board of directors of ANI Pharmaceuticals and Nanoform.

How do I contact Jeanne Thoma?: The corporate mailing address for Ms. Thoma and other ANI Pharmaceuticals executives is 210 Main Street West, Baudette MN, 56623. ANI Pharmaceuticals can also be reached via phone at (218) 634-3500 and via email at [email protected]. Learn More on Jeanne Thoma's contact information.
Has Jeanne Thoma been buying or selling shares of ANI Pharmaceuticals?: Jeanne Thoma has not been actively trading shares of ANI Pharmaceuticals during the last quarter. Most recently, on Monday, December 20th, Jeanne Thoma bought 1,072 shares of ANI Pharmaceuticals stock. The stock was acquired at an average cost of $46.47 per share, with a total value of $49,815.84. Learn More on Jeanne Thoma's trading history.
Who are ANI Pharmaceuticals' active insiders?: ANI Pharmaceuticals' insider roster includes Stephen Carey (CFO), Thomas Haughey (Director), Nikhil Lalwani (Pres), Muthusamy Shanmugam (Head of R&D and COO), Jeanne Thoma (Director), and Patrick Walsh (Director). Learn More on ANI Pharmaceuticals' active insiders.
Are insiders buying or selling shares of ANI Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 44 times. They sold a total of 778,234 shares worth more than $45,770,310.97. The most recent insider tranaction occured on April, 17th when COO Muthusamy Shanmugam sold 9,520 shares worth more than $622,608.00. Insiders at ANI Pharmaceuticals own 12.7% of the company. Learn More about insider trades at ANI Pharmaceuticals.
Information on this page was last updated on 4/17/2024.

Jeanne Thoma Insider Trading History at ANI Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/20/2021	Buy	1,072	$46.47	$49,815.84

Jeanne Thoma Buying and Selling Activity at ANI Pharmaceuticals

ANI Pharmaceuticals Company Overview

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Today's Range

Now: $65.10

$64.20

$65.10

50 Day Range

MA: $64.77

$55.02

$69.69

2 Week Range

Now: $65.10

$36.99

$70.81

Volume

6,947 shs

Average Volume

137,012 shs

Market Capitalization

$1.37 billion

P/E Ratio

77.50

Dividend Yield

N/A

Beta

0.79

AI “wealth window” is closing soon!

From Paradigm Press | Ad

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

I put together this personal video [HERE]…